Company intelligence / Profile preview

Signal Advance

Houston, Texas, United Statessignaladvance.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The company has demonstrated proof-of-concept for temporally advanced detection of analog/bioelectric signals using its proprietary Negative Group Delay technology. No clinical trial results reported; focus is on enabling technologies rather than therapeutics or diagnostics per se

Therapeutic areas: Other
Modalities: DeviceNon-pharmacological therapy (signal processing hardware for bioelectric signals)
Industry: Physiological Monitoring

Partnerships

Actively seeking strategic partners in biomedicine and other sectors

Beyond the preview

Go deeper on Signal Advance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal Advance.

Explore the full profile